I now have all the content needed from Park's PSM. Here is the full, organized answer:
Criteria for Screening (PSM)
(Source: Park's Textbook of Preventive and Social Medicine)
Before starting any screening programme, it must have ethical, scientific, and financial justification. The criteria are divided into two broad categories: the Disease and the Screening Test.
A. Criteria Related to the DISEASE
The disease must fulfil all of the following before screening is considered worthwhile:
| # | Criterion |
|---|
| 1 | The condition should be an important health problem (high prevalence) |
| 2 | There should be a recognizable latent or early asymptomatic stage |
| 3 | The natural history of the disease (latent to declared) should be adequately understood |
| 4 | There must be a test that can detect the disease before signs and symptoms appear |
| 5 | Facilities for confirmation of diagnosis must be available |
| 6 | There must be an effective treatment available |
| 7 | There must be an agreed-on policy about whom to treat (e.g., borderline blood pressure, borderline diabetes) |
| 8 | Early detection and treatment must reduce morbidity and mortality (good evidence required) |
| 9 | Expected benefits (lives saved) must exceed the risks and costs |
Only when the above disease criteria are satisfied is it appropriate to consider a suitable screening test.
B. Criteria Related to the SCREENING TEST
The test must satisfy all of the following:
1. Acceptability
- The test must be acceptable to the population
- Tests that are painful, discomforting, or embarrassing (e.g., rectal/vaginal exams) have poor uptake in mass campaigns
- High cooperation rate is necessary
2. Repeatability (Reliability / Precision)
The test must give consistent results on repeated application. Variability can arise from three sources:
- Observer variation - intra-observer (same observer, different times) and inter-observer (different observers) variability
- Subject/biological variation - e.g., blood pressure fluctuations, regression to the mean
- Technical/method errors - defective instruments, faulty reagents, calibration errors
3. Validity (Accuracy)
The test must accurately distinguish diseased from non-diseased individuals. Validity has two components:
- Sensitivity - ability to correctly identify those WITH the disease (true positive rate)
- Specificity - ability to correctly identify those WITHOUT the disease (true negative rate)
4. Yield
- The number of previously unrecognized cases brought to treatment as a result of screening
- Influenced by: sensitivity of the test, prevalence of the disease, proportion of the population screened
5. Simplicity
- Should be simple enough to be performed by paramedical/auxiliary staff
6. Safety
- Must be safe with minimal or no risk to the individual
7. Rapidity
- Should be rapid to screen large numbers in a short time
8. Ease of Administration
- Can be easily organized and delivered in a community setting
9. Cost
- Cost must be economically balanced in relation to benefits (cost-effectiveness)
Classic Reference: Wilson & Jungner Criteria (WHO, 1968)
These Park's criteria are derived from the 10 original Wilson & Jungner principles published by the WHO. The key additions from W&J are:
- The treatment for cases found should be acceptable to the population
- Case-finding should be a continuous process, not a once-and-for-all project
Quick Memory Aid
For Disease criteria: "INN LEAP"
- Important health problem
- Natural history understood
- No symptoms yet (latent stage exists)
- Lab/test available
- Effective treatment
- Agreed policy on treatment
- Profit (benefit > risk/cost) + Proof of benefit from early Rx
For Test criteria: "A²R²V + SSeC"
- Acceptability, Accuracy (validity), Repeatability, Rapidity, Validity - Simplicity, Safety, economic/Cost, Coverage/yield
- Park's Textbook of Preventive and Social Medicine, pp. 157-160 (Criteria for Screening section)